Cortechs.ai | Expanded Scanner Options for NeuroQuant: Toshiba and Hitachi

Expanded Scanner Options for NeuroQuant: Toshiba and Hitachi

Cortechs.ai | Expanded Scanner Options for NeuroQuant: Toshiba and HitachiThe Cortechs.ai Engineering team is very excited to announce that NeuroQuant is now compatible with 1.5T Toshiba and Hitachi MRI scanners. These additional scanner options greatly benefit our customers, offering the ability use NeuroQuant brain segmentation accurately and consistently on these scanners, in addition to 1.5T and 3.0T GE, Philips and Siemens and Toshiba Titian 3T MRI scanners.

Over the past few months, Cortechs.ai engineering team validated the 1.5T Toshiba and Hitachi MRI scanners to ensure accurate and consistent brain segmentation results. The findings were impressive. The both scanners showed excellent image quality and contrast allowing for accurate segmentation, and was found to be on par with other validated vendors.

The incorporation of the 1.5T Toshiba and Hitachi scanners into NeuroQuant scanner compatibility allows physicians and researchers more freedom in MRI scanner choices when using NeuroQuant for additional supportive volumetric data to enrich their clinical treatment planning and disease progression monitoring of patients with neurodegenerative conditions, such as multiple sclerosis, Alzheimer’s disease, epilepsy and traumatic brain injury.

Our updated recommended scanner settings can be found here.

Download Now

Like this post? You might also find these interesting.

Cortechs.ai | Expanded Scanner Options for NeuroQuant: Toshiba and Hitachi

More Resources

03/20/2026

Quantitative MRI, the McDonald Criteria, and the Future of Multiple Sclerosis Care

MRI is the foundation for diagnosing and monitoring multiple sclerosis (MS)

03/13/2026

Cortechs Cares: Community Impact and Volunteer Efforts in 2025

Cortechs Cares highlights how our team gave back in 2025 through community volunteer efforts, including an Alzheimer’s Walk and holiday toy drive.

03/11/2026

OnQ™ Prostate: Bringing Quantitative MRI to Prostate Imaging

Advancing prostate MRI with quantitative diffusion biomarkers. OnQ™ Prostate brings objective RSI-based insights to support data-driven cancer evaluation.

03/04/2026

Cortechs.ai and Siemens Healthineers Partner to Expand Global Access to NeuroQuant® Technologies

NeuroQuant® Lesion Surveillance will be integrated into the Siemens Healthineers Digital Marketplace to advance quantitative brain imaging worldwide.

02/25/2026

Cortechs.ai Announces MFDS (KFDA) Approval of Global-Leading NeuroQuant® V5 Platform in South Korea

MFDS approves NeuroQuant® V5 in South Korea, expanding AI-driven volumetric neuroimaging and clinical decision support.

02/24/2026

Financial Conflict Of Interest Policy Applicable To NIH Awards

Scroll to Top